FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing to remove from the market a common ingredient found in most oral over-the ...
Cure Today4d
Keytruda Has Long-Term Survivorship Implications in Early Triple-Negative Breast Cancer
Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...
Business Insider5d
IO Biotech reports data on IO102-IO103 vaccine in combination with KEYTRUDA
IO Biotech (IOBT) announced data from the NSCLC cohort in the company’s Phase 2 basket trial of IO102-IO103, the company’s lead investigational candidate, given in combination with Merck’s anti-PD-1 ...